Combination Therapy [topp]
Low dose [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Oral [spco]
Estrogen [horm, phsu, strd]
Affect [menp]
Endothelial [tisu]
function [phsf]
Forearms [bpoc]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
investigated [ftcn]
Low dose [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Combined [qlco]
Oral [spco]
Estrogen [horm, phsu, strd]
adverse effects [ftcn]
Endothelial [tisu]
function [phsf]
Compared [acty]
Oral [spco]
Estrogen [horm, phsu, strd]
Alone [qnco]
postmenopausal [tmco]
Women [popg]
Mild [qlco]
Hypercholesterolaemia [dsyn]
Design [acty]
Subject [grup]
divided [ftcn]
Group [idcn]
Group [idcn]
Received [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
cee [orch]
mg% [qnco]
Daily [tmco]
Orally [spco]
months [tmco]
Estrogen [horm, phsu, strd]
Combined [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
Daily [tmco]
Orally [spco]
Additional [ftcn]
months [tmco]
N NOS [aapp, imft]
Group [idcn]
Received [qlco]
treatment [ftcn]
Control Group [grup]
N NOS [aapp, imft]
Forearm [bpoc]
Blood flow [orgf]
Reactive Hyperemia [patf]
Administration, Sublingual [ftcn]
Nitroglycerin [orch, phsu]
Measured [qlco]
Strain gauge plethysmography [diap]
Nitrite [chvs]
Nitrate [chvs]
Angiotensin Converting Enzyme [aapp, enzy, imft]
Lipid [lipd]
Concentrations [menp]
Measured [qlco]
cee [orch]
cee [orch]
Combined [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Increased [qnco]
Forearm [bpoc]
Blood flow [orgf]
Reactive Hyperemia [patf]
Active Treatment [topp]
Phases [tmco]
Seen [qlco]
Forearm [bpoc]
Blood flow [orgf]
Sublingual [ftcn]
Nitroglycerin [orch, phsu]
months [tmco]
Group [idcn]
increases [ftcn]
serum concentration [qnco]
Nitrite [chvs]
Nitrate [chvs]
Plasma [bdsu]
renin activity [moft]
Decrease [qlco]
angiotensin converting enzyme activity [moft]
treatment [ftcn]
Phases [tmco]
Occurred [acty]
Control Group [grup]
High Density Lipoprotein Cholesterol [bacs, lipd]
Decrease [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
treatment [ftcn]
Phases [tmco]
Observed [ftcn]
Control Group [grup]
Conclusions [idcn]
Study [mnob]
Suggest [idcn]
Addition [ftcn]
Low dose [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
cee [orch]
adverse effects [ftcn]
Forearm [bpoc]
Resistance [menp]
Artery Endothelium [tisu]
function [phsf]
Compared [acty]
cee [orch]
Alone [qnco]
